Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - Fortress Biotech, Inc. | d548746d10q.htm |
| EX-31.1 - EX-31.1 - Fortress Biotech, Inc. | d548746dex311.htm |
| EX-31.2 - EX-31.2 - Fortress Biotech, Inc. | d548746dex312.htm |
| EX-32.2 - EX-32.2 - Fortress Biotech, Inc. | d548746dex322.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Fortress Biotech, Inc. | Financial_Report.xls |
Exhibit 32.1
CORONADO BIOSCIENCES, INC.
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Coronado Biosciences, Inc. on Form 10-Q for the quarterly period ended June 30, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I Harlan F. Weisman, Chief Executive Officer, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his or her knowledge and belief:
(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the company, as of, and for, the periods presented in the Report.
August 5, 2013
| By: | /s/ Harlan F. Weisman | |
| Harlan F. Weisman | ||
| Chief Executive Officer | ||
| (Principal Executive Officer) |